US20040231909A1 - Motorized vehicle having forward and backward differential structure - Google Patents
Motorized vehicle having forward and backward differential structure Download PDFInfo
- Publication number
- US20040231909A1 US20040231909A1 US10/440,861 US44086103A US2004231909A1 US 20040231909 A1 US20040231909 A1 US 20040231909A1 US 44086103 A US44086103 A US 44086103A US 2004231909 A1 US2004231909 A1 US 2004231909A1
- Authority
- US
- United States
- Prior art keywords
- motorized vehicle
- propeller shaft
- thrust bearings
- direction thrust
- bearing seat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Definitions
- the present invention relates to a motorized vehicle, and more particularly to a motorized vehicle having a forward and backward differential structure.
- a conventional motorized vehicle comprises a differential mounted on the transmission gear of the gear box.
- the differential consists of a bevel gear set.
- the power of the motor is reduced by the reduction mechanism.
- the reduced power is transmitted by the transmission gear of the gear box and the bevel gear of the differential to the propeller shafts at the left and right sides, to drive and rotate the wheels at the left and right sides.
- the motorized vehicle is turned, the turning diameter of the wheel at the inner side is shorter than that of the wheel at the outer side, so that the differential consisting of the bevel gear set is used to balance the difference of the rotation speed between the wheel at the inner side and the wheel at the outer side.
- the primary objective of the present invention is to provide a motorized vehicle having a forward and backward differential structure.
- Another objective of the present invention is to provide a motorized vehicle, wherein when the two rear wheels are subjected to a drag or resistance and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearing will idle, thereby producing a differential effect.
- a further objective of the present invention is to provide a motorized vehicle, wherein the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward.
- a further objective of the present invention is to provide a motorized vehicle having a differential structure which can replace the conventional differential consisting of a bevel gear set, thereby reducing costs of fabrication, and thereby simplifying the construction.
- a motorized vehicle comprising:
- a propeller shaft mounted on the two rear wheels and having two ends;
- the single-direction thrust bearings located between one of the two rear wheels and a first end of the propeller shaft has a rotation direction opposite to a normal rotation direction of the propeller shaft to drive the motorized vehicle to move forward;
- the single-direction thrust bearings located between the other one of the two rear wheels and a second end of the propeller shaft has a rotation direction opposite to a reverse rotation direction of the propeller shaft to drive the motorized vehicle to move backward.
- FIG. 1 is a partially exploded perspective view of a motorized vehicle in accordance with the preferred embodiment of the present invention
- FIG. 2 is a front plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1;
- FIG. 3 is a top plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1;
- FIG. 4 is a perspective assembly view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention.
- FIG. 5 is an exploded perspective view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention.
- FIG. 6 is a side plan cross-sectional view of the differential structure of the motorized vehicle as shown in FIG. 4;
- FIG. 7 is a schematic top plan operational view showing the turning state of the motorized vehicle in accordance with the preferred embodiment of the present invention.
- FIG. 8 is a side plan cross-sectional assembly view showing the normal transmission state of the motorized vehicle in accordance with the preferred embodiment of the present invention.
- FIG. 9 is a side plan cross-sectional assembly view showing the differential state of the motorized vehicle in accordance with the preferred embodiment of the present invention.
- a motorized vehicle 10 having a forward and backward differential structure in accordance with the preferred embodiment of the present invention has a rear portion provided with a propeller shaft 11 having two ends each provided with a catch flange 12 , a keyway 13 (see FIG. 6), and an outer thread 14 (see FIG. 6).
- Each of the two ends of the propeller shaft 11 is provided with a bearing cap 20 , two single-direction thrust bearings 30 , a bearing seat 40 , and a fixing member 50 .
- the bearing seat 40 is formed with a plurality of screw bores 41 .
- the bearing cap 20 is formed with a plurality of through holes 21 .
- the motorized vehicle 10 further comprises a plurality of locking screws 22 each extended through a respective one of the through holes 21 and each screwed into a respective one of the screw bores 41 , thereby fixing the bearing cap 20 on the bearing seat 40 .
- Each of the two single-direction thrust bearings 30 is mounted between the bearing seat 40 and the propeller shaft 11 .
- Each of the two single-direction thrust bearings 30 has an inner race formed with an inner keyway 31 .
- the motorized vehicle 10 further comprises a first key 32 secured in the inner keyway 31 of each of the two single-direction thrust bearings 30 and the keyway 13 of the propeller shaft 11 , so that each of the two single-direction thrust bearings 30 is combined with the propeller shaft 11 .
- Each of the two single-direction thrust bearings 30 has an outer race formed with an outer keyway 310 .
- the bearing seat 40 has two sides each formed with a keyway 42 .
- the motorized vehicle 10 further comprises two second keys 320 each secured in the outer keyway 310 of a respective one of the two single-direction thrust bearings 30 and the keyway 42 of the bearing seat 40 , so that each of the two single-direction thrust bearings 30 is combined with the bearing seat 40 .
- One of the two single-direction thrust bearings 30 is rested on and limited by the catch flange 12 of the propeller shaft 11 and the bearing cap 20 .
- the fixing member 50 is secured on the propeller shaft 11 and is rested on the other one of the two single-direction thrust bearings 30 .
- the fixing member 50 is formed with an inner thread 51 screwed on the outer thread 14 of the propeller shaft 11 , so that the fixing member 50 is fixed on the propeller shaft 11 .
- the bearing seat 40 has a periphery provided with a fixing board 43 , and the motorized vehicle 10 further comprises two rear wheels 60 each secured on the fixing board 43 of the respective bearing seat 40 .
- the fixing board 43 of the bearing seat 40 is formed with a plurality of through holes 44 .
- Each of the two rear wheels 60 is formed with a plurality of through holes 62 .
- the motorized vehicle 10 further comprises a plurality of locking bolts 45 each extended through a respective one of the through holes 44 of the fixing board 43 of the bearing seat 40 and a respective one of the through holes 62 of the respective rear wheel 60 , so that each of the two rear wheels 60 is fixed on the fixing board 43 of the respective bearing seat 40 .
- the two single-direction thrust bearings 30 located at a first end of the propeller shaft 11 has a rotation direction opposite to the normal rotation direction (when the motorized vehicle 10 is moved forward) of the propeller shaft 11 to drive the motorized vehicle 10 to move forward
- the two single-direction thrust bearings 30 located at a second end of the propeller shaft 11 has a rotation direction opposite to the reverse rotation direction (when the motorized vehicle 10 is moved backward) of the propeller shaft 11 to drive the motorized vehicle 10 to move backward.
- the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward.
- the single-direction thrust bearing will idle, thereby producing a differential effect.
- the motorized vehicle is driven by the two rear wheels.
- the single-direction thrust bearings located at the left rear wheel is used to drive the motorized vehicle to move forward.
- the single-direction thrust bearings located at the right rear wheel idles.
- the single-direction thrust bearings located at the right rear wheel is used to drive the motorized vehicle to move backward.
- the single-direction thrust bearings located at the left rear wheel idles.
- the single-direction thrust bearings mounted on the two rear wheels form a differential effect when the motorized vehicle is turned or driven on an abnormal road condition.
Abstract
A motorized vehicle includes a plurality of single-direction thrust bearings mounted between each of the two rear wheels and the propeller shaft. The single-direction thrust bearings located at one rear wheel is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located at the other rear wheel is used to drive the motorized vehicle to move backward. Thus, when the two rear wheels are subjected to a drag and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearings will idle, thereby producing a differential effect.
Description
- 1. Field of the Invention
- The present invention relates to a motorized vehicle, and more particularly to a motorized vehicle having a forward and backward differential structure.
- 2. Description of the Related Art
- A conventional motorized vehicle comprises a differential mounted on the transmission gear of the gear box. The differential consists of a bevel gear set. The power of the motor is reduced by the reduction mechanism. Then, the reduced power is transmitted by the transmission gear of the gear box and the bevel gear of the differential to the propeller shafts at the left and right sides, to drive and rotate the wheels at the left and right sides. When the motorized vehicle is turned, the turning diameter of the wheel at the inner side is shorter than that of the wheel at the outer side, so that the differential consisting of the bevel gear set is used to balance the difference of the rotation speed between the wheel at the inner side and the wheel at the outer side.
- However, the conventional differential consisting of a bevel gear set has a complicated construction, thereby increasing costs of fabrication, and thereby causing inconvenience in assembly and maintenance.
- The primary objective of the present invention is to provide a motorized vehicle having a forward and backward differential structure.
- Another objective of the present invention is to provide a motorized vehicle, wherein when the two rear wheels are subjected to a drag or resistance and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearing will idle, thereby producing a differential effect.
- A further objective of the present invention is to provide a motorized vehicle, wherein the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward.
- A further objective of the present invention is to provide a motorized vehicle having a differential structure which can replace the conventional differential consisting of a bevel gear set, thereby reducing costs of fabrication, and thereby simplifying the construction.
- In accordance with the present invention, there is provided a motorized vehicle, comprising:
- two rear wheels;
- a propeller shaft mounted on the two rear wheels and having two ends; and
- a plurality of single-direction thrust bearings mounted between each of the two rear wheels and the propeller shaft, wherein:
- the single-direction thrust bearings located between one of the two rear wheels and a first end of the propeller shaft has a rotation direction opposite to a normal rotation direction of the propeller shaft to drive the motorized vehicle to move forward; and
- the single-direction thrust bearings located between the other one of the two rear wheels and a second end of the propeller shaft has a rotation direction opposite to a reverse rotation direction of the propeller shaft to drive the motorized vehicle to move backward.
- Further benefits and advantages of the present invention will become apparent after a careful reading of the detailed description with appropriate reference to the accompanying drawings.
- FIG. 1 is a partially exploded perspective view of a motorized vehicle in accordance with the preferred embodiment of the present invention;
- FIG. 2 is a front plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1;
- FIG. 3 is a top plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1;
- FIG. 4 is a perspective assembly view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention;
- FIG. 5 is an exploded perspective view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention;
- FIG. 6 is a side plan cross-sectional view of the differential structure of the motorized vehicle as shown in FIG. 4;
- FIG. 7 is a schematic top plan operational view showing the turning state of the motorized vehicle in accordance with the preferred embodiment of the present invention;
- FIG. 8 is a side plan cross-sectional assembly view showing the normal transmission state of the motorized vehicle in accordance with the preferred embodiment of the present invention; and
- FIG. 9 is a side plan cross-sectional assembly view showing the differential state of the motorized vehicle in accordance with the preferred embodiment of the present invention.
- Referring to the drawings and initially to FIGS. 1-6, a motorized
vehicle 10 having a forward and backward differential structure in accordance with the preferred embodiment of the present invention has a rear portion provided with apropeller shaft 11 having two ends each provided with acatch flange 12, a keyway 13 (see FIG. 6), and an outer thread 14 (see FIG. 6). - Each of the two ends of the
propeller shaft 11 is provided with abearing cap 20, two single-direction thrust bearings 30, abearing seat 40, and afixing member 50. - The
bearing seat 40 is formed with a plurality ofscrew bores 41. Thebearing cap 20 is formed with a plurality of throughholes 21. Themotorized vehicle 10 further comprises a plurality oflocking screws 22 each extended through a respective one of the throughholes 21 and each screwed into a respective one of thescrew bores 41, thereby fixing thebearing cap 20 on thebearing seat 40. - Each of the two single-
direction thrust bearings 30 is mounted between thebearing seat 40 and thepropeller shaft 11. Each of the two single-direction thrust bearings 30 has an inner race formed with aninner keyway 31. - The motorized
vehicle 10 further comprises afirst key 32 secured in theinner keyway 31 of each of the two single-direction thrust bearings 30 and thekeyway 13 of thepropeller shaft 11, so that each of the two single-direction thrust bearings 30 is combined with thepropeller shaft 11. - Each of the two single-
direction thrust bearings 30 has an outer race formed with anouter keyway 310. Thebearing seat 40 has two sides each formed with akeyway 42. The motorizedvehicle 10 further comprises twosecond keys 320 each secured in theouter keyway 310 of a respective one of the two single-direction thrust bearings 30 and thekeyway 42 of thebearing seat 40, so that each of the two single-direction thrust bearings 30 is combined with thebearing seat 40. - One of the two single-
direction thrust bearings 30 is rested on and limited by thecatch flange 12 of thepropeller shaft 11 and thebearing cap 20. - The
fixing member 50 is secured on thepropeller shaft 11 and is rested on the other one of the two single-direction thrust bearings 30. Preferably, thefixing member 50 is formed with aninner thread 51 screwed on theouter thread 14 of thepropeller shaft 11, so that thefixing member 50 is fixed on thepropeller shaft 11. - The
bearing seat 40 has a periphery provided with afixing board 43, and the motorizedvehicle 10 further comprises tworear wheels 60 each secured on thefixing board 43 of therespective bearing seat 40. - The
fixing board 43 of thebearing seat 40 is formed with a plurality of throughholes 44. Each of the tworear wheels 60 is formed with a plurality of throughholes 62. The motorizedvehicle 10 further comprises a plurality oflocking bolts 45 each extended through a respective one of the throughholes 44 of thefixing board 43 of thebearing seat 40 and a respective one of the throughholes 62 of the respectiverear wheel 60, so that each of the tworear wheels 60 is fixed on thefixing board 43 of therespective bearing seat 40. - In addition, the two single-
direction thrust bearings 30 located at a first end of thepropeller shaft 11 has a rotation direction opposite to the normal rotation direction (when the motorizedvehicle 10 is moved forward) of thepropeller shaft 11 to drive the motorizedvehicle 10 to move forward, while the two single-direction thrust bearings 30 located at a second end of thepropeller shaft 11 has a rotation direction opposite to the reverse rotation direction (when themotorized vehicle 10 is moved backward) of thepropeller shaft 11 to drive the motorizedvehicle 10 to move backward. - In operation, referring to FIGS. 7-9 with reference to FIGS. 1-6, when the
motorized vehicle 10 is turned around, therear wheel 60 at the inner side cannot be rotated with thepropeller shaft 11 synchronously. At this time, the single-direction thrust bearing 30 idles, thereby producing a differential effect, thereby reducing the turning diameter of the motorizedvehicle 10, and thereby reducing wear of therear wheels 60. - Accordingly, the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward. Thus, when the two rear wheels are subjected to a drag or resistance and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearing will idle, thereby producing a differential effect.
- In practice, the motorized vehicle is driven by the two rear wheels. For example, the single-direction thrust bearings located at the left rear wheel is used to drive the motorized vehicle to move forward. At this time, the single-direction thrust bearings located at the right rear wheel idles. On the contrary, the single-direction thrust bearings located at the right rear wheel is used to drive the motorized vehicle to move backward. At this time, the single-direction thrust bearings located at the left rear wheel idles. Thus, the single-direction thrust bearings mounted on the two rear wheels form a differential effect when the motorized vehicle is turned or driven on an abnormal road condition.
- Although the invention has been explained in relation to its preferred embodiment(s) as mentioned above, it is to be understood that many other possible modifications and variations can be made without departing from the scope of the present invention. It is, therefore, contemplated that the appended claim or claims will cover such modifications and variations that fall within the true scope of the invention.
Claims (11)
1. A motorized vehicle, comprising:
two rear wheels;
a propeller shaft mounted on the two rear wheels and having two ends; and
a plurality of single-direction thrust bearings mounted between each of the two rear wheels and the propeller shaft, wherein:
the single-direction thrust bearings located between one of the two rear wheels and a first end of the propeller shaft has a rotation direction opposite to a normal rotation direction of the propeller shaft to drive the motorized vehicle to move forward; and
the single-direction thrust bearings located between the other one of the two rear wheels and a second end of the propeller shaft has a rotation direction opposite to a reverse rotation direction of the propeller shaft to drive the motorized vehicle to move backward.
2. The motorized vehicle in accordance with claim 1 , wherein each of the two ends of the propeller shaft is provided with a bearing cap, two single-direction thrust bearings, a bearing seat, and a fixing member.
3. The motorized vehicle in accordance with claim 2 , wherein the bearing seat is formed with a plurality of screw bores, the bearing cap is formed with a plurality of through holes, and the motorized vehicle further comprises a plurality of locking screws each extended through a respective one of the through holes and each screwed into a respective one of the screw bores, thereby fixing the bearing cap on the bearing seat.
4. The motorized vehicle in accordance with claim 2 , wherein each of the two single-direction thrust bearings is mounted between the bearing seat and the propeller shaft.
5. The motorized vehicle in accordance with claim 2 , wherein each of the two ends of the propeller shaft is formed with a keyway, each of the two single-direction thrust bearings has an inner race formed with an inner keyway, and the motorized vehicle further comprises a first key secured in the inner keyway of each of the two single-direction thrust bearings and the keyway of the propeller shaft, so that each of the two single-direction thrust bearings is combined with the propeller shaft.
6. The motorized vehicle in accordance with claim 2 , wherein each of the two single-direction thrust bearings has an outer race formed with an outer keyway, the bearing seat has two sides each formed with a keyway, and the motorized vehicle further comprises two second keys each secured in the outer keyway of a respective one of the two single-direction thrust bearings and the keyway of the bearing seat, so that each of the two single-direction thrust bearings is combined with the bearing seat.
7. The motorized vehicle in accordance with claim 2 , wherein each of the two ends of the propeller shaft is formed with a catch flange, one of the two single-direction thrust bearings is rested on and limited by the catch flange of the propeller shaft and the bearing cap.
8. The motorized vehicle in accordance with claim 7 , wherein the fixing member is secured on the propeller shaft and is rested on the other one of the two single-direction thrust bearings.
9. The motorized vehicle in accordance with claim 2 , wherein each of the two ends of the propeller shaft is formed with an outer thread, and the fixing member is formed with an inner thread screwed on the outer thread of the propeller shaft, so that the fixing member is fixed on the propeller shaft.
10. The motorized vehicle in accordance with claim 2 , wherein the bearing seat has a periphery provided with a fixing board, and each of the two rear wheels is secured on the fixing board of the respective bearing seat.
11. The motorized vehicle in accordance with claim 10 , wherein the fixing board of the bearing seat is formed with a plurality of through holes, each of the two rear wheels is formed with a plurality of through holes, and the motorized vehicle further comprises a plurality of locking bolts each extended through a respective one of the through holes of the fixing board of the bearing seat and a respective one of the through holes of the respective rear wheel, so that each of the two rear wheels is fixed on the fixing board of the respective bearing seat.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44086103P | 2003-01-15 | 2003-01-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040231909A1 true US20040231909A1 (en) | 2004-11-25 |
Family
ID=32771871
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/440,861 Abandoned US20040231909A1 (en) | 2003-01-15 | 2003-05-19 | Motorized vehicle having forward and backward differential structure |
US10/758,307 Active 2025-04-21 US7569345B2 (en) | 2003-01-15 | 2004-01-14 | Gene expression markers for breast cancer prognosis |
US12/478,632 Active 2024-05-25 US8034565B2 (en) | 2003-01-15 | 2009-06-04 | Gene expression markers for breast cancer prognosis |
US13/221,549 Expired - Lifetime US8206919B2 (en) | 2003-01-15 | 2011-08-30 | Gene expression markers for breast cancer prognosis |
US13/473,526 Expired - Lifetime US8741605B2 (en) | 2003-01-15 | 2012-05-16 | Gene expression markers for breast cancer prognosis |
US14/257,723 Active 2026-07-13 US9944990B2 (en) | 2003-01-15 | 2014-04-21 | Gene expression markers for breast cancer prognosis |
US15/897,617 Active 2024-06-17 US11220715B2 (en) | 2003-01-15 | 2018-02-15 | Gene expression markers for breast cancer prognosis |
Family Applications After (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/758,307 Active 2025-04-21 US7569345B2 (en) | 2003-01-15 | 2004-01-14 | Gene expression markers for breast cancer prognosis |
US12/478,632 Active 2024-05-25 US8034565B2 (en) | 2003-01-15 | 2009-06-04 | Gene expression markers for breast cancer prognosis |
US13/221,549 Expired - Lifetime US8206919B2 (en) | 2003-01-15 | 2011-08-30 | Gene expression markers for breast cancer prognosis |
US13/473,526 Expired - Lifetime US8741605B2 (en) | 2003-01-15 | 2012-05-16 | Gene expression markers for breast cancer prognosis |
US14/257,723 Active 2026-07-13 US9944990B2 (en) | 2003-01-15 | 2014-04-21 | Gene expression markers for breast cancer prognosis |
US15/897,617 Active 2024-06-17 US11220715B2 (en) | 2003-01-15 | 2018-02-15 | Gene expression markers for breast cancer prognosis |
Country Status (11)
Country | Link |
---|---|
US (7) | US20040231909A1 (en) |
EP (4) | EP3059322B1 (en) |
JP (1) | JP4723472B2 (en) |
AT (1) | ATE470723T1 (en) |
AU (2) | AU2004205878B2 (en) |
CA (5) | CA3013889A1 (en) |
DE (1) | DE602004027600D1 (en) |
DK (3) | DK2230319T3 (en) |
ES (3) | ES2561179T3 (en) |
HK (1) | HK1148783A1 (en) |
WO (1) | WO2004065583A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103465779A (en) * | 2013-09-17 | 2013-12-25 | 哈尔滨工程大学 | Double-engine type omni-directional four-wheel drive traveling mechanism |
Families Citing this family (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8044259B2 (en) * | 2000-08-03 | 2011-10-25 | The Regents Of The University Of Michigan | Determining the capability of a test compound to affect solid tumor stem cells |
US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
US20060062786A1 (en) * | 2000-11-08 | 2006-03-23 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
US7361341B2 (en) * | 2001-05-25 | 2008-04-22 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to trail receptors |
US20050129616A1 (en) * | 2001-05-25 | 2005-06-16 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
US20090226429A1 (en) * | 2001-05-25 | 2009-09-10 | Human Genome Sciences, Inc. | Antibodies That Immunospecifically Bind to TRAIL Receptors |
US7348003B2 (en) | 2001-05-25 | 2008-03-25 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors |
US20050214209A1 (en) * | 2001-05-25 | 2005-09-29 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
US20030180296A1 (en) * | 2001-12-20 | 2003-09-25 | Theodora Salcedo | Antibodies that immunospecifically bind to trail receptors |
ES2685702T3 (en) * | 2002-03-13 | 2018-10-10 | Genomic Health, Inc. | Obtaining gene expression profile in biopsied tumor tissues |
US20040231909A1 (en) * | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
EP2775000B1 (en) * | 2003-06-24 | 2016-11-09 | Genomic Health, Inc. | Prediction of likelihood of cancer recurrence |
CA2531967C (en) | 2003-07-10 | 2013-07-16 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
US20060003391A1 (en) * | 2003-08-11 | 2006-01-05 | Ring Brian Z | Reagents and methods for use in cancer diagnosis, classification and therapy |
US20050112622A1 (en) | 2003-08-11 | 2005-05-26 | Ring Brian Z. | Reagents and methods for use in cancer diagnosis, classification and therapy |
WO2005100606A2 (en) * | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
US20080131916A1 (en) * | 2004-08-10 | 2008-06-05 | Ring Brian Z | Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy |
JP5117852B2 (en) * | 2004-08-10 | 2013-01-16 | カーディフ バイオロジカルズ リミテッド | Prognosis method and kit for breast cancer |
CA2580795A1 (en) * | 2004-09-22 | 2006-04-06 | Tripath Imaging, Inc. | Methods and compositions for evaluating breast cancer prognosis |
US8065093B2 (en) * | 2004-10-06 | 2011-11-22 | Agency For Science, Technology, And Research | Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers |
ES2384107T3 (en) * | 2004-11-05 | 2012-06-29 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and treatment response prediction |
ES2778851T3 (en) * | 2004-11-05 | 2020-08-12 | Genomic Health Inc | Prediction of response to chemotherapy using gene expression markers |
CA2587519A1 (en) * | 2004-12-07 | 2006-06-15 | Genentech, Inc. | Selecting patients for therapy with a her inhibitor |
WO2006078307A1 (en) | 2005-01-21 | 2006-07-27 | Genentech, Inc. | Fixed dosing of her antibodies |
US20060188509A1 (en) | 2005-02-23 | 2006-08-24 | Genentech, Inc. | Extending time to disease progression or survival in cancer patients |
US20080275652A1 (en) * | 2005-05-13 | 2008-11-06 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
JP2006316040A (en) | 2005-05-13 | 2006-11-24 | Genentech Inc | Herceptin(r) adjuvant treatment |
US20070099209A1 (en) * | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
CA2620195A1 (en) * | 2005-08-24 | 2007-03-01 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
EP1945754B1 (en) | 2005-10-31 | 2014-07-23 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
EP1946118A4 (en) | 2005-11-10 | 2009-01-21 | Aurelium Biopharma Inc | Tissue diagnostics for breast cancer |
TW200731980A (en) * | 2005-12-29 | 2007-09-01 | Alcon Mfg Ltd | RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis |
WO2007123772A2 (en) | 2006-03-31 | 2007-11-01 | Genomic Health, Inc. | Genes involved in estrogen metabolism |
EP2390360A1 (en) * | 2006-06-02 | 2011-11-30 | GlaxoSmithKline Biologicals S.A. | Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the IDO1 gene |
WO2008063521A2 (en) * | 2006-11-13 | 2008-05-29 | The General Hospital Corporation | Gene-based clinical scoring system |
WO2008092002A2 (en) | 2007-01-24 | 2008-07-31 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing pancreatic cancer |
PE20090681A1 (en) | 2007-03-02 | 2009-06-10 | Genentech Inc | PREDICTION OF RESPONSE TO A HER INHIBITOR |
JP5631201B2 (en) | 2007-03-28 | 2014-11-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Stitched polypeptide |
WO2008150512A2 (en) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Methods for identifying an increased likelihood of recurrence of breast cancer |
US9551033B2 (en) * | 2007-06-08 | 2017-01-24 | Genentech, Inc. | Gene expression markers of tumor resistance to HER2 inhibitor treatment |
ES2583377T3 (en) | 2007-06-08 | 2016-09-20 | Genentech, Inc. | Gene expression markers of tumor resistance to HER2 inhibitor treatment |
EP2191020A2 (en) * | 2007-08-16 | 2010-06-02 | Genomic Health, Inc. | Gene expression markers of recurrence risk in cancer patients after chemotherapy |
GB0720113D0 (en) * | 2007-10-15 | 2007-11-28 | Cambridge Cancer Diagnostics L | Diagnostic, prognostic and predictive testing for cancer |
WO2009067655A2 (en) * | 2007-11-21 | 2009-05-28 | University Of Florida Research Foundation, Inc. | Methods of feature selection through local learning; breast and prostate cancer prognostic markers |
EP2065475A1 (en) * | 2007-11-30 | 2009-06-03 | Siemens Healthcare Diagnostics GmbH | Method for therapy prediction in tumors having irregularities in the expression of at least one VEGF ligand and/or at least one ErbB-receptor |
US20110130296A1 (en) * | 2008-03-14 | 2011-06-02 | The Regents Of The University Of California | Multi-gene classifiers and prognostic indicators for cancers |
BRPI0812682A2 (en) | 2008-06-16 | 2010-06-22 | Genentech Inc | metastatic breast cancer treatment |
US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
US20100221752A2 (en) * | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
US20110195995A1 (en) * | 2008-10-14 | 2011-08-11 | Wittliff James L | Methods of Optimizing Treatment of Estrogen-Receptor Positive Breast Cancers |
GB0821787D0 (en) * | 2008-12-01 | 2009-01-07 | Univ Ulster | A genomic-based method of stratifying breast cancer patients |
US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
CA2761280A1 (en) | 2009-05-29 | 2010-12-02 | F. Hoffmann-La Roche Ag | Modulators for her2 signaling in her2 expressing patients with gastric cancer |
US20120225789A1 (en) * | 2009-05-29 | 2012-09-06 | Baylor College Of Medicine | Dna repair or brca1-like gene signature |
WO2010146059A2 (en) | 2009-06-16 | 2010-12-23 | F. Hoffmann-La Roche Ag | Biomarkers for igf-1r inhibitor therapy |
EP2275569A1 (en) * | 2009-07-17 | 2011-01-19 | Centre Leon Berard | ZNF217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in cancer |
GB0917457D0 (en) * | 2009-10-06 | 2009-11-18 | Glaxosmithkline Biolog Sa | Method |
AU2010321829B2 (en) * | 2009-11-23 | 2015-07-30 | Genomic Health, Inc. | Methods to predict clinical outcome of cancer |
WO2011088137A2 (en) * | 2010-01-12 | 2011-07-21 | H. Lee Moffitt Cancer Center & Research Institute | Bad pathway gene signature |
US20130143753A1 (en) * | 2010-03-01 | 2013-06-06 | Adelbio | Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom |
WO2011146568A1 (en) | 2010-05-19 | 2011-11-24 | Genentech, Inc. | Predicting response to a her inhibitor |
EP2591126B1 (en) | 2010-07-07 | 2020-12-30 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
KR101870123B1 (en) | 2010-07-09 | 2018-06-25 | 소마로직, 인크. | Lung cancer biomarkers and uses thereof |
DK2603600T3 (en) | 2010-08-13 | 2019-03-04 | Aileron Therapeutics Inc | PEPTIDOMIMETIC MACROCYCLES |
MX350533B (en) | 2010-08-13 | 2017-09-08 | Somalogic Inc | Pancreatic cancer biomarkers and uses thereof. |
WO2012030840A2 (en) | 2010-08-30 | 2012-03-08 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
WO2012070056A2 (en) | 2010-11-23 | 2012-05-31 | Krisani Biosciences (P) Ltd | Method and system for prognosis and treatment of diseases using portfolio of genes |
WO2012109233A2 (en) * | 2011-02-07 | 2012-08-16 | Board Of Regents, The University Of Texas System | Methods for predicting recurrence risk in breast cancer patients |
MX358886B (en) | 2011-10-18 | 2018-08-31 | Aileron Therapeutics Inc | Peptidomimetic macrocyles. |
WO2013070521A1 (en) * | 2011-11-08 | 2013-05-16 | Genomic Health, Inc. | Method of predicting breast cancer prognosis |
WO2013083810A1 (en) | 2011-12-09 | 2013-06-13 | F. Hoffmann-La Roche Ag | Identification of non-responders to her2 inhibitors |
AU2013221433B2 (en) | 2012-02-15 | 2018-01-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
WO2013170174A1 (en) | 2012-05-10 | 2013-11-14 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist of cell death (bad) pathway gene signature |
US9890430B2 (en) | 2012-06-12 | 2018-02-13 | Washington University | Copy number aberration driven endocrine response gene signature |
BR112015009470A2 (en) | 2012-11-01 | 2019-12-17 | Aileron Therapeutics Inc | disubstituted amino acids and their methods of preparation and use |
EP2920322B1 (en) | 2012-11-16 | 2023-01-11 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
EP2926142B2 (en) | 2012-11-30 | 2022-07-06 | F. Hoffmann-La Roche AG | Identification of patients in need of pd-l1 inhibitor cotherapy |
JP2016505043A (en) | 2013-01-18 | 2016-02-18 | クライン,エリス | Selective glycosidase regimens for immune programming and cancer treatment |
EP2954331B1 (en) | 2013-02-11 | 2018-03-28 | Incuron LLC | Use of facilitates chromatin transcription complex (fact) in cancer |
CN103558382B (en) * | 2013-10-28 | 2015-11-18 | 深圳市第二人民医院 | The application of CCNE1 gene on detecting in bladder transitional cell carcinoma |
CN103558383B (en) * | 2013-10-28 | 2015-11-18 | 深圳市第二人民医院 | The application of ALDH2 gene on detecting in bladder transitional cell carcinoma |
KR20150088433A (en) | 2014-01-24 | 2015-08-03 | 삼성전자주식회사 | Biomarker TFF1 for predicting effect of a c-Met inhibitor |
EP3623482A1 (en) | 2014-05-13 | 2020-03-18 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
US10633710B2 (en) | 2014-08-15 | 2020-04-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for characterizing cancer |
CN112245565A (en) | 2014-09-24 | 2021-01-22 | 艾瑞朗医疗公司 | Peptidomimetic macrocycles and uses thereof |
SG10201902598VA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and formulations thereof |
AU2015334841B2 (en) | 2014-10-24 | 2022-02-03 | Koninklijke Philips N.V. | Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities |
CN108064380A (en) | 2014-10-24 | 2018-05-22 | 皇家飞利浦有限公司 | Use the prediction of the medical prognosis and therapeutic response of various kinds of cell signal transduction path activity |
ES2833543T3 (en) | 2014-10-24 | 2021-06-15 | Koninklijke Philips Nv | Evaluation of the activity of the TGF cell signaling pathway using mathematical models of target gene expression |
SG11201707750YA (en) | 2015-03-20 | 2017-10-30 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
EP3073268A1 (en) * | 2015-03-27 | 2016-09-28 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Biomarker panel for diagnosing cancer |
DK3334837T3 (en) | 2015-08-14 | 2021-02-15 | Koninklijke Philips Nv | EVALUATION OF NFKB CELLULAR SIGNALING VEHICLE ACTIVITY USING MATHEMATICAL MODELING OF MOAL EXPRESSION |
CN107058523A (en) * | 2017-03-21 | 2017-08-18 | 温州迪安医学检验所有限公司 | A kind of genetic test primer of breast carcinoma recurring risk assessment 21 and its application |
EP3461915A1 (en) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression |
EP3502279A1 (en) | 2017-12-20 | 2019-06-26 | Koninklijke Philips N.V. | Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression |
CN110045120A (en) * | 2018-01-15 | 2019-07-23 | 长庚医疗财团法人基隆长庚纪念医院 | Detect detection kit and its application of the concentration of WISP1 in biological sample in preparation for breast cancer screening and detecting recurrence |
WO2020013355A1 (en) * | 2018-07-10 | 2020-01-16 | 서울대학교산학협력단 | Composition for predicting prognosis of malignant phyllodes tumor and kit comprising same |
EP4013896A4 (en) * | 2019-08-12 | 2023-09-20 | Baylor College of Medicine | Proteogenomic methods for diagnosing cancer |
CN113862363A (en) * | 2021-10-27 | 2021-12-31 | 中山大学附属第一医院 | Application of immune related gene in kit and system for breast cancer prognosis |
CN114480650A (en) * | 2022-02-08 | 2022-05-13 | 深圳市陆为生物技术有限公司 | Marker and model for predicting three-negative breast cancer clinical prognosis recurrence risk |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6378397B1 (en) * | 2000-10-25 | 2002-04-30 | Jenn Jianq Co., Ltd. | Differential gearing device |
US6655515B2 (en) * | 2001-05-24 | 2003-12-02 | Tecumseh Products Company | Modular bi-directional overrunning wheel clutch |
Family Cites Families (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE56509B1 (en) | 1982-11-04 | 1991-08-28 | Univ California | Methods for oncogenic detection |
USRE35491E (en) | 1982-11-04 | 1997-04-08 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
US4699877A (en) | 1982-11-04 | 1987-10-13 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
US7838216B1 (en) | 1986-03-05 | 2010-11-23 | The United States Of America, As Represented By The Department Of Health And Human Services | Human gene related to but distinct from EGF receptor gene |
US5015568A (en) | 1986-07-09 | 1991-05-14 | The Wistar Institute | Diagnostic methods for detecting lymphomas in humans |
US5202429A (en) | 1986-07-09 | 1993-04-13 | The Wistar Institute | DNA molecules having human BCL-2 gene sequences |
US4968603A (en) | 1986-12-31 | 1990-11-06 | The Regents Of The University Of California | Determination of status in neoplastic disease |
US5831066A (en) | 1988-12-22 | 1998-11-03 | The Trustees Of The University Of Pennsylvania | Regulation of bcl-2 gene expression |
US5922855A (en) * | 1993-12-17 | 1999-07-13 | Oregon Health Sciences University | Mammalian DNA mismatch repair genes MLH1 and PMS1 |
US6037134A (en) * | 1994-03-07 | 2000-03-14 | New York University Medical Center | Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes |
US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
US5858678A (en) | 1994-08-02 | 1999-01-12 | St. Louis University | Apoptosis-regulating proteins |
US5830753A (en) | 1994-09-30 | 1998-11-03 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof. |
US6218529B1 (en) * | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
CA2239692C (en) | 1995-12-18 | 2008-12-16 | Sugen, Inc. | Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
US6716575B2 (en) | 1995-12-18 | 2004-04-06 | Sugen, Inc. | Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
US5670325A (en) | 1996-08-14 | 1997-09-23 | Exact Laboratories, Inc. | Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample |
US5741650A (en) | 1996-01-30 | 1998-04-21 | Exact Laboratories, Inc. | Methods for detecting colon cancer from stool samples |
US5821082A (en) | 1996-05-23 | 1998-10-13 | St. Louis University Health Sciences Center | Anti-proliferation domain of a human Bcl-2 and DNA encoding the same |
CA2744096C (en) | 1996-07-31 | 2013-07-30 | Laboratory Corporation Of America Holdings | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US5928870A (en) | 1997-06-16 | 1999-07-27 | Exact Laboratories, Inc. | Methods for the detection of loss of heterozygosity |
US6100029A (en) | 1996-08-14 | 2000-08-08 | Exact Laboratories, Inc. | Methods for the detection of chromosomal aberrations |
US6203993B1 (en) | 1996-08-14 | 2001-03-20 | Exact Science Corp. | Methods for the detection of nucleic acids |
US5952178A (en) | 1996-08-14 | 1999-09-14 | Exact Laboratories | Methods for disease diagnosis from stool samples |
US6143529A (en) | 1996-08-14 | 2000-11-07 | Exact Laboratories, Inc. | Methods for improving sensitivity and specificity of screening assays |
US6020137A (en) | 1996-08-14 | 2000-02-01 | Exact Laboratories, Inc. | Methods for the detection of loss of heterozygosity |
US6146828A (en) | 1996-08-14 | 2000-11-14 | Exact Laboratories, Inc. | Methods for detecting differences in RNA expression levels and uses therefor |
US5861278A (en) | 1996-11-01 | 1999-01-19 | Genetics Institute, Inc. | HNF3δ compositions |
ATE414149T1 (en) | 1996-11-20 | 2008-11-15 | Univ Yale | SURVIVIN, A PROTEIN THAT INHIBITS CELLULAR APOPTOSIS AND ITS MODULATION |
US5830665A (en) | 1997-03-03 | 1998-11-03 | Exact Laboratories, Inc. | Contiguous genomic sequence scanning |
US6033893A (en) | 1997-06-26 | 2000-03-07 | Incyte Pharmaceuticals, Inc. | Human cathepsin |
WO1999002714A1 (en) | 1997-07-07 | 1999-01-21 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
DE69836823D1 (en) * | 1997-10-21 | 2007-02-15 | Univ Glasgow | JMY, MIT ACTIVATOR FOR P300 / CBP, FOR CODING END NUCLEIC ACID AND ITS USES |
WO1999044062A1 (en) * | 1998-02-25 | 1999-09-02 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Cellular arrays for rapid molecular profiling |
US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
EP1084273A1 (en) | 1998-06-06 | 2001-03-21 | Genostic Pharma Limited | Probes used for genetic profiling |
AU4158799A (en) | 1998-06-06 | 1999-12-30 | Genostic Pharma Limited | Probes used for genetic filing |
US6696558B2 (en) | 1998-09-09 | 2004-02-24 | The Burnham Institute | Bag proteins and nucleic acid molecules encoding them |
AU2342900A (en) | 1998-09-23 | 2000-05-01 | Cleveland Clinic Foundation, The | Novel interferon stimulated and repressed genes |
US6251601B1 (en) | 1999-02-02 | 2001-06-26 | Vysis, Inc. | Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
US9534254B1 (en) | 1999-02-02 | 2017-01-03 | Abbott Molecular Inc. | Patient stratification for cancer therapy based on genomic DNA microarray analysis |
AU3246200A (en) | 1999-02-25 | 2000-09-14 | Boris Bilynsky | Nucleic acid molecules associated with melanoma and thyroid tumors |
US20020039764A1 (en) | 1999-03-12 | 2002-04-04 | Rosen Craig A. | Nucleic, acids, proteins, and antibodies |
AU3395900A (en) | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
US6692916B2 (en) | 1999-06-28 | 2004-02-17 | Source Precision Medicine, Inc. | Systems and methods for characterizing a biological condition or agent using precision gene expression profiles |
US6960439B2 (en) | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
US6326148B1 (en) | 1999-07-12 | 2001-12-04 | The Regents Of The University Of California | Detection of copy number changes in colon cancer |
US6710170B2 (en) | 1999-09-10 | 2004-03-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
US6271002B1 (en) | 1999-10-04 | 2001-08-07 | Rosetta Inpharmatics, Inc. | RNA amplification method |
CA2391805A1 (en) | 1999-10-06 | 2001-04-12 | The Regents Of The University Of California | Differentially expressed genes associated with her-2/neu overexpression |
EP1690872A3 (en) | 1999-12-01 | 2006-08-23 | Genentech, Inc. | Composition and methods for the diagnosis of tumours |
US6750013B2 (en) | 1999-12-02 | 2004-06-15 | Protein Design Labs, Inc. | Methods for detection and diagnosing of breast cancer |
US6248535B1 (en) | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
WO2001051664A2 (en) * | 2000-01-12 | 2001-07-19 | Dana-Farber Cancer Institute, Inc. | Method of detecting and characterizing a neoplasm |
EP1276901A2 (en) | 2000-01-13 | 2003-01-22 | Amsterdam Support Diagnostics B.V. | A universal nucleic acid amplification system for nucleic acids in a sample |
US6322986B1 (en) | 2000-01-18 | 2001-11-27 | Albany Medical College | Method for colorectal cancer prognosis and treatment selection |
US6618679B2 (en) | 2000-01-28 | 2003-09-09 | Althea Technologies, Inc. | Methods for analysis of gene expression |
WO2001055312A2 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
US20030165831A1 (en) | 2000-03-21 | 2003-09-04 | John Lee | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |
US7157227B2 (en) | 2000-03-31 | 2007-01-02 | University Of Louisville Research Foundation | Microarrays to screen regulatory genes |
WO2002000677A1 (en) | 2000-06-07 | 2002-01-03 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2002008461A2 (en) | 2000-07-21 | 2002-01-31 | Global Genomics Ab | A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS |
AU2001278076A1 (en) | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-5 proteins and related reagents and methods of use thereof |
WO2002008260A2 (en) | 2000-07-26 | 2002-01-31 | Stanford University | Bstp-ecg1 protein and related reagents and methods of use thereof |
AU2001277202A1 (en) | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-ras/rerg protein and related reagents and methods of use thereof |
WO2002010436A2 (en) * | 2000-07-28 | 2002-02-07 | The Brigham And Women's Hospital, Inc. | Prognostic classification of breast cancer |
US7795232B1 (en) | 2000-08-25 | 2010-09-14 | Genta Incorporated | Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
US6602670B2 (en) | 2000-12-01 | 2003-08-05 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 expression |
US6582919B2 (en) | 2001-06-11 | 2003-06-24 | Response Genetics, Inc. | Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates |
WO2002046467A2 (en) | 2000-12-08 | 2002-06-13 | Ipsogen | Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
WO2002068579A2 (en) | 2001-01-10 | 2002-09-06 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
US7097966B2 (en) | 2001-01-12 | 2006-08-29 | Yale University | Detection of survivin in the biological fluids of cancer patients |
US7776518B2 (en) | 2001-01-12 | 2010-08-17 | Yale University | Detection of survivin in the biological fluids of cancer patients |
JP2005503760A (en) | 2001-01-24 | 2005-02-10 | プロテイン デザイン ラブス, インコーポレイテッド | Breast cancer diagnosis method, composition and breast cancer modulator screening method |
AU2002253878A1 (en) * | 2001-01-25 | 2002-08-06 | Gene Logic, Inc. | Gene expression profiles in breast tissue |
WO2002073204A2 (en) | 2001-03-12 | 2002-09-19 | Monogen, Inc | Cell-based detection and differentiation of disease states |
US20050260572A1 (en) | 2001-03-14 | 2005-11-24 | Kikuya Kato | Method of predicting cancer |
EP1410011B1 (en) | 2001-06-18 | 2011-03-23 | Rosetta Inpharmatics LLC | Diagnosis and prognosis of breast cancer patients |
US7125680B2 (en) | 2001-07-27 | 2006-10-24 | The Regents Of The University Of California | Methods and materials for characterizing and modulating interaction between heregulin and HER3 |
US6898531B2 (en) * | 2001-09-05 | 2005-05-24 | Perlegen Sciences, Inc. | Algorithms for selection of primer pairs |
EP1444361A4 (en) | 2001-09-28 | 2006-12-27 | Whitehead Biomedical Inst | Classification of lung carcinomas using gene expression analysis |
WO2003040404A1 (en) | 2001-11-09 | 2003-05-15 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
ES2685702T3 (en) | 2002-03-13 | 2018-10-10 | Genomic Health, Inc. | Obtaining gene expression profile in biopsied tumor tissues |
WO2003083096A2 (en) | 2002-03-28 | 2003-10-09 | Qlt Inc. | Cancer associated protein kinases and their uses |
EP1365034A3 (en) | 2002-05-21 | 2004-02-18 | Bayer HealthCare AG | Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia |
EP2284266B1 (en) * | 2002-11-14 | 2013-11-06 | Thermo Fisher Scientific Biosciences Inc. | siRNA targeting tp53 |
WO2004061423A2 (en) * | 2003-01-06 | 2004-07-22 | Wyeth | Compositions and methods for diagnosing and treating colon cancers |
US20040231909A1 (en) * | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
ATE412779T1 (en) | 2003-02-20 | 2008-11-15 | Genomic Health Inc | USE OF INTRONIC RNA SEQUENCES TO QUANTIFY GENE EXPRESSION |
AU2004248120B2 (en) | 2003-05-28 | 2009-04-23 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
EP2775000B1 (en) * | 2003-06-24 | 2016-11-09 | Genomic Health, Inc. | Prediction of likelihood of cancer recurrence |
CA2531967C (en) | 2003-07-10 | 2013-07-16 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
WO2005100606A2 (en) | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
ES2384107T3 (en) | 2004-11-05 | 2012-06-29 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and treatment response prediction |
ES2778851T3 (en) | 2004-11-05 | 2020-08-12 | Genomic Health Inc | Prediction of response to chemotherapy using gene expression markers |
JP2009506777A (en) | 2005-09-01 | 2009-02-19 | プレシジョン セラピューティクス,インコーポレイテッド | Chemotherapy sensitivity assay using tumor cells with resistant phenotypic characteristics |
EP1777523A1 (en) | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
WO2007123772A2 (en) | 2006-03-31 | 2007-11-01 | Genomic Health, Inc. | Genes involved in estrogen metabolism |
EP2191020A2 (en) | 2007-08-16 | 2010-06-02 | Genomic Health, Inc. | Gene expression markers of recurrence risk in cancer patients after chemotherapy |
ES2403220T3 (en) | 2008-05-12 | 2013-05-16 | Genomic Health, Inc. | Tests to predict the receptivity of cancer patients to chemotherapy treatment options |
BRPI1013997A2 (en) | 2009-07-02 | 2016-04-05 | Basf Se | method for producing a co-agglomerated dispersion, aqueous dispersion, foamed polymer, method for producing a foamed polymer, latex-based adhesive, method of adhering a substrate to a surface, modified asphalt composition. |
AU2010321829B2 (en) | 2009-11-23 | 2015-07-30 | Genomic Health, Inc. | Methods to predict clinical outcome of cancer |
-
2003
- 2003-05-19 US US10/440,861 patent/US20040231909A1/en not_active Abandoned
-
2004
- 2004-01-14 WO PCT/US2004/000985 patent/WO2004065583A2/en active Application Filing
- 2004-01-14 CA CA3013889A patent/CA3013889A1/en not_active Abandoned
- 2004-01-14 DK DK10162868.3T patent/DK2230319T3/en active
- 2004-01-14 DE DE602004027600T patent/DE602004027600D1/en not_active Expired - Lifetime
- 2004-01-14 JP JP2006500964A patent/JP4723472B2/en not_active Expired - Lifetime
- 2004-01-14 DK DK15190640.1T patent/DK3059322T3/en active
- 2004-01-14 CA CA2829476A patent/CA2829476C/en not_active Expired - Lifetime
- 2004-01-14 CA CA2829477A patent/CA2829477C/en not_active Expired - Lifetime
- 2004-01-14 EP EP15190640.1A patent/EP3059322B1/en not_active Expired - Lifetime
- 2004-01-14 CA CA2829472A patent/CA2829472C/en not_active Expired - Lifetime
- 2004-01-14 DK DK04702177.9T patent/DK1587957T3/en active
- 2004-01-14 AT AT04702177T patent/ATE470723T1/en active
- 2004-01-14 EP EP10162868.3A patent/EP2230319B1/en not_active Expired - Lifetime
- 2004-01-14 ES ES10162868.3T patent/ES2561179T3/en not_active Expired - Lifetime
- 2004-01-14 ES ES04702177T patent/ES2346967T3/en not_active Expired - Lifetime
- 2004-01-14 AU AU2004205878A patent/AU2004205878B2/en not_active Expired
- 2004-01-14 US US10/758,307 patent/US7569345B2/en active Active
- 2004-01-14 EP EP10162867A patent/EP2230318A1/en not_active Ceased
- 2004-01-14 ES ES15190640T patent/ES2725892T3/en not_active Expired - Lifetime
- 2004-01-14 EP EP04702177A patent/EP1587957B1/en not_active Expired - Lifetime
- 2004-01-14 CA CA2513117A patent/CA2513117C/en not_active Expired - Lifetime
-
2009
- 2009-06-04 US US12/478,632 patent/US8034565B2/en active Active
- 2009-11-16 AU AU2009238287A patent/AU2009238287B2/en not_active Expired
-
2011
- 2011-03-17 HK HK11102676.4A patent/HK1148783A1/en not_active IP Right Cessation
- 2011-08-30 US US13/221,549 patent/US8206919B2/en not_active Expired - Lifetime
-
2012
- 2012-05-16 US US13/473,526 patent/US8741605B2/en not_active Expired - Lifetime
-
2014
- 2014-04-21 US US14/257,723 patent/US9944990B2/en active Active
-
2018
- 2018-02-15 US US15/897,617 patent/US11220715B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6378397B1 (en) * | 2000-10-25 | 2002-04-30 | Jenn Jianq Co., Ltd. | Differential gearing device |
US6655515B2 (en) * | 2001-05-24 | 2003-12-02 | Tecumseh Products Company | Modular bi-directional overrunning wheel clutch |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103465779A (en) * | 2013-09-17 | 2013-12-25 | 哈尔滨工程大学 | Double-engine type omni-directional four-wheel drive traveling mechanism |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040231909A1 (en) | Motorized vehicle having forward and backward differential structure | |
EP2365917B1 (en) | Final drive for a work machine | |
US20110120794A1 (en) | Chain Gear, Vehicle Comprising a Chain Gear and Method for Transforming a motor Torque in a Vehicle | |
EP0962349A2 (en) | Power transmission device | |
US6080077A (en) | Planetary gear drive train | |
US4729257A (en) | Balanced steerable transmission | |
JP2012067925A (en) | Reduction gear | |
SE504653C2 (en) | Compact gearbox with large gear ratio | |
JPH10278813A (en) | Electric power steering device | |
US20070290478A1 (en) | Bicycle | |
US20020130483A1 (en) | Chainless transmission mechanism for bicycles | |
ATE315485T1 (en) | TWIN WHEELS WITH DIFFERENTIAL | |
US6689009B1 (en) | Compact differential assembly | |
US6776737B2 (en) | Planetary differential gear | |
KR200336799Y1 (en) | Transmission mechanism with a single differential mechanism | |
JP4072234B2 (en) | Clutch device | |
US5088969A (en) | Bifurcated transmission drive | |
JP2008281159A (en) | Differential device | |
US20060270511A1 (en) | Differential gear apparatus | |
EP1467125A2 (en) | Planetary differential gear | |
KR20080007295A (en) | Boat | |
CN220320221U (en) | Equal center distance transmission structure | |
US999876A (en) | Worm-drive and compensating gearing. | |
US6318197B1 (en) | Speed changeable gear drive apparatus for a wheeled vehicle | |
KR100993795B1 (en) | Power transmission apparatus for vehicle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TAIWAN POWER INDUSTRIAL CO., LTD., TAIWAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LUH, TAI-YANG;REEL/FRAME:014095/0612 Effective date: 20030505 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |